Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Myriad Genetics (MYGN) over the last 15 years, with Q3 2025 value amounting to $2.9 million.

  • Myriad Genetics' Change in Inventory changed N/A to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 21764.71%. This contributed to the annual value of $6.2 million for FY2024, which is 24444.44% up from last year.
  • Latest data reveals that Myriad Genetics reported Change in Inventory of $2.9 million as of Q3 2025.
  • In the past 5 years, Myriad Genetics' Change in Inventory ranged from a high of $4.3 million in Q3 2022 and a low of -$3.2 million during Q4 2021
  • Its 5-year average for Change in Inventory is $744444.4, with a median of $850000.0 in 2021.
  • Its Change in Inventory has fluctuated over the past 5 years, first plummeted by 19230.77% in 2021, then soared by 75000.0% in 2023.
  • Over the past 5 years, Myriad Genetics' Change in Inventory (Quarter) stood at -$3.2 million in 2021, then surged by 53.12% to -$1.5 million in 2022, then tumbled by 113.33% to -$3.2 million in 2023, then skyrocketed by 140.62% to $1.3 million in 2024, then soared by 123.08% to $2.9 million in 2025.
  • Its Change in Inventory stands at $2.9 million for Q3 2025, versus $300000.0 for Q2 2025 and $900000.0 for Q1 2025.